Kubota Pharmaceutical Holdings Co., Ltd. (4596) Other
Market cap
¥11.2B
P/E ratio
Kubota Pharmaceutical develops innovative eye disease treatments including wearable myopia devices and pharmaceuticals for conditions like diabetic retinopathy.
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | -46 | -39.9 | -53.5 | -8.1 | -7.3 | -11.9 | -7.2 | -12.4 | -14.6 | -13.7 |
| Return on equity (%) | ||||||||||
| Employees | 44 | 34 | 20 | 12 | 8 | 8 | 7 | 12 | 19 | 8 |